+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Olmesartan"

Anti-Hypertensive Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Hypertensive Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Global and Chinese Olmesartan Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Olmesartan Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 143 Pages
  • China, Global
From
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

The Olmesartan market is a segment of the Cardiovascular Drugs market. Olmesartan is an angiotensin II receptor antagonist used to treat hypertension and congestive heart failure. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. Olmesartan is available in both generic and branded forms. The Olmesartan market is highly competitive, with a number of major players offering a range of products. Companies in the market include Daiichi Sankyo, Mylan, Teva Pharmaceuticals, Lupin Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more